Revolutionizing Cancer detection and Treatment 

Here at LAM, we are dedicated to nullifying the threat of cancer. Research shows that the key to this, is to identify the presence of cancer in its infancy and begin taking steps immediately to halt its progress. Our mission is to revolutionize the process of early diagnosis and prognosis and ultimately, to finding lasting treatment for the disease.

LAM’s experts are perpetually working to bring cutting-edge technology in early detection to the healthcare market place. With goals of affordability and availability for all, LAM will endeavor to bring these technologies to your doorstep.

With an estimated almost 40% of adults in the U.S. being diagnosed with cancer at some point in their lifetime, it is imperative that we unlock the key to eradicating this disease.

LAM strives to galvanize the healthcare industry into changing standards of care by identifying cancer early and reducing or even eliminating long, intense treatment regimens.


Featured Service

The IvyGene test is a blood test that uses advanced DNA sequencing methods to detect the DNA methylation pattern of circulating tumor DNA (ctDNA) in blood samples in order to both confirm the presence of cancer and give quantitative data about disease presence.

DNA Methylation has a firm foundation in science and is now being used for revolutionary new methods.

Learn More

Latest News

Biotech Showcase Press Release

Click here for information

New Conferences

We are excited to be attending some new, prestigious conferences this fall. We hope to see many of our physician partners at many of these events. IvyGene will be represented at an exhibit booth, please make sure to stop by!

Learn more about DNA Methylation

The building blocks of IvyGene were published in Nature Materials! Learn more about DNA Methylation and how this technology is being used in revolutionary new ways. Visit the link to learn more:

Product Launch

The owners of ONCOblot are excited to launch the IvyGene test in the beginning of 2018. The IvyGene test is a ground-breaking new blood test that uses Next Generation Sequencing methods to detect the DNA methylation pattern of ctDNA in plasma samples in order to both confirm the presence of methylation patterns consistent with disease presence and to identify the possible tissue of origin.

Our website IvyGeneLabs will be available soon. In order to review publications and literature, please contact customer service at [email protected]


9950 Research Drive Irvine, CA